Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Richard Koche

Showing results (41-50 of 71) with videos related to

Pageof 8
Sort By:
Cancer Cell|January 13, 2026
Characterization of a pathogenic subpopulation of human glioma associated macrophages linked to glioma progressionKenny Kwok Hei Yu, Zaki Abou-Mrad, Kristof Törkenczy, et al.
Biorxiv : the Preprint Server for Biology|March 3, 2025
A pathogenic subpopulation of human glioma associated macrophages linked to glioma progressionKenny Kwok Hei Yu, Zaki Abou-Mrad, Kristof Törkenczy, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 22, 2023
Development of Resistance to Type II JAK2 Inhibitors in MPN Depends on AXL Kinase and Is TargetableTamara Codilupi, Jakub Szybinski, Stefanie Arunasalam, et al.
Cancer Cell|December 4, 2014
AF10 regulates progressive H3K79 methylation and HOX gene expression in diverse AML subtypesAniruddha J Deshpande, Anagha Deshpande, Amit U Sinha, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 30, 2021
Therapeutic Efficacy of Combined JAK1/2, Pan-PIM, and CDK4/6 Inhibition in Myeloproliferative NeoplasmsRaajit K Rampal, Maria Pinzon-Ortiz, Amritha Varshini Hanasoge Somasundara, et al.
Biorxiv : the Preprint Server for Biology|April 16, 2025
Enhanced FLI1 accessibility mediates STAG2-mutant leukemogenesisJane J Xu, Viviana Scoca, Yi Chen, et al.
Biorxiv : the Preprint Server for Biology|August 23, 2023
Interferon response and epigenetic modulation by <i>SMARCA4</i> mutations drive ovarian tumor immunogenicityMelica Nourmoussavi Brodeur, Higinio Dopeso, Yingjie Zhu, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 4, 2015
Targeting MYCN-Driven Transcription By BET-Bromodomain InhibitionAnton Henssen, Kristina Althoff, Andrea Odersky, et al.
Cell Stem Cell|September 10, 2019
Cohesin Members Stag1 and Stag2 Display Distinct Roles in Chromatin Accessibility and Topological Control of HSC Self-Renewal and DifferentiationAaron D Viny, Robert L Bowman, Yu Liu, et al.
Nature|February 4, 2021
A gene-environment-induced epigenetic program initiates tumorigenesisDirena Alonso-Curbelo, Yu-Jui Ho, Cassandra Burdziak, et al.
Pageof 8

Showing results (41-50 of 71) with videos related to

Sort By:
Pageof 8
Cancer Cell|January 13, 2026
Characterization of a pathogenic subpopulation of human glioma associated macrophages linked to glioma progressionKenny Kwok Hei Yu, Zaki Abou-Mrad, Kristof Törkenczy, et al.
Biorxiv : the Preprint Server for Biology|March 3, 2025
A pathogenic subpopulation of human glioma associated macrophages linked to glioma progressionKenny Kwok Hei Yu, Zaki Abou-Mrad, Kristof Törkenczy, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 22, 2023
Development of Resistance to Type II JAK2 Inhibitors in MPN Depends on AXL Kinase and Is TargetableTamara Codilupi, Jakub Szybinski, Stefanie Arunasalam, et al.
Cancer Cell|December 4, 2014
AF10 regulates progressive H3K79 methylation and HOX gene expression in diverse AML subtypesAniruddha J Deshpande, Anagha Deshpande, Amit U Sinha, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 30, 2021
Therapeutic Efficacy of Combined JAK1/2, Pan-PIM, and CDK4/6 Inhibition in Myeloproliferative NeoplasmsRaajit K Rampal, Maria Pinzon-Ortiz, Amritha Varshini Hanasoge Somasundara, et al.
Biorxiv : the Preprint Server for Biology|April 16, 2025
Enhanced FLI1 accessibility mediates STAG2-mutant leukemogenesisJane J Xu, Viviana Scoca, Yi Chen, et al.
Biorxiv : the Preprint Server for Biology|August 23, 2023
Interferon response and epigenetic modulation by <i>SMARCA4</i> mutations drive ovarian tumor immunogenicityMelica Nourmoussavi Brodeur, Higinio Dopeso, Yingjie Zhu, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 4, 2015
Targeting MYCN-Driven Transcription By BET-Bromodomain InhibitionAnton Henssen, Kristina Althoff, Andrea Odersky, et al.
Cell Stem Cell|September 10, 2019
Cohesin Members Stag1 and Stag2 Display Distinct Roles in Chromatin Accessibility and Topological Control of HSC Self-Renewal and DifferentiationAaron D Viny, Robert L Bowman, Yu Liu, et al.
Nature|February 4, 2021
A gene-environment-induced epigenetic program initiates tumorigenesisDirena Alonso-Curbelo, Yu-Jui Ho, Cassandra Burdziak, et al.
Pageof 8